Race, Natriuretic Peptides and Physiological Perturbations
种族、利尿钠肽和生理干扰
基本信息
- 批准号:9900851
- 负责人:
- 金额:$ 19.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-01 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:Adipose tissueAdrenergic beta-AntagonistsAdultAfrican AmericanAlabamaAtrial Natriuretic FactorAwardBiologicalBiological Response Modifier TherapyBiometryBrain natriuretic peptideCardiovascular DiseasesCardiovascular systemCerebrovascular DisordersCessation of lifeClassificationClinical ResearchClinical SciencesCollectionCommunitiesDevelopmentDietDiseaseDisease susceptibilityEnrollmentEpidemiologyEthicsExcretory functionExerciseExercise PhysiologyFive-Year PlansFundingGeneticGenetic MarkersGoalsGrantGuanosine MonophosphateHeartHeart AtriumHeart failureHigh PrevalenceHormonesHospitalizationHumanHypertensionImpairmentIndividualInternationalInterventionIntervention StudiesKidneyKnowledgeLeadershipMaster of ScienceMeasuresMedicineMentored Patient-Oriented Research Career Development AwardMentorsMentorshipMetabolicMetabolismMethodsMetoprololMetoprolol SuccinateN-terminalNatriuretic PeptidesOutcomeOxygenParticipantPatientsPeriodicityPharmaceutical PreparationsPharmacologyPharmacology StudyPhysiologicalPhysiologyPrevalencePrincipal InvestigatorProductionProtocols documentationPublic HealthPublic Health SchoolsRaceRenin-Angiotensin-Aldosterone SystemResearchResearch DesignResearch PersonnelRestSkeletal MuscleSodiumSodium ChlorideSpecimenStandardizationStressSubgroupSystemSystems BiologyTestingThinnessTimeTrainingTranslational ResearchUnderrepresented MinorityUniversitiesVO2maxVasodilationWorkWritingcardiovascular disorder riskcardiovascular healthcollaborative environmentdesignefficacy testingexperiencegenetic testinghealth disparityhemodynamicshypertension treatmentinsightinterestnew therapeutic targetnormotensivenovel therapeuticspatient orientedpatient oriented researchpersonalized medicinephysiologic stressorprimary endpointprofessorprogramsracial and ethnic disparitiesracial differenceracial disparityrecruitresponsesecondary endpointskillssocialsocial health determinantsuptakeurinaryvalsartan
项目摘要
PROJECT SUMMARY/ABSTRACT
The applicant, Pankaj Arora, MD is an Assistant Professor of Medicine in the Division of Cardiovascular
Disease at University of Alabama at Birmingham. The applicant’s goal is to become an independent
investigator in clinical and translational research and advance the understanding of how disorders in the
natriuretic peptide (NP) system contribute to the development of hypertension, heart failure and cardiovascular
disease. The applicant has shown a prior interest in understanding the genetics, NP system biology and an
ability to conduct high-quality patient-oriented research. This Mentored Patient-Oriented Research Career
Development Award (K23) describes a five-year plan that will allow the applicant to achieve independence as
an investigator, under the primary mentorship of Thomas J. Wang MD, an internationally-recognized leader in
the field of NP physiology. The applicant wishes to obtain knowledge and expertise in 4 specific domains: (1)
patient-oriented physiologic studies, (2) the pathophysiologic basis of race-related differences in cardiovascular
disease susceptibility, (3) exercise physiology, and (4) patient-oriented pharmacologic studies.
African-Americans have increased prevalence of cardiovascular disease which contributes to racial disparities
in outcomes such as death and hospitalization. NPs are natriuretic and vasodilatory hormones produced by
the heart in response to increased wall stress in the atria and ventricles. In preliminary work for this proposal,
we found that African-American race is associated with NP deficiency. Little is known about the physiological
consequences of the lower resting NP levels found in African-Americans. The current proposal will seek to
determine if there exists racial differences in how the heart responds to physiological perturbations such as
exercise and beta blockers. The specific aims are (1) To compare the NP response to beta blockers in African-
American and white individuals (2) To compare the NP response to exercise in African-American and white
individuals. Understanding these differences in release of NPs may have biological and therapeutic
importance in the treatment of hypertension and heart failure.
The Mentored Patient-Oriented Research Career Development award (K23) will provide Dr. Arora with the
necessary time to fully engage in multifaceted, carefully designed patient-oriented research protocols while
serving as a means to receive additional formal didactics. During the course of the award period, the applicant
will pursue a Master of Science in Public Health in Clinical & Translational Science at UAB’s School of Public
Health to advance his skills in patient-oriented research (epidemiology, biostatistics, study design, grant-
writing, and leadership courses). UAB’s rich collaborative, interdisciplinary environment with national
recognition for community engagement will provide Dr. Arora with a platform to successfully conduct the
research proposed in the plan. The proposed studies will prepare the investigator to design and conduct
interventional studies (e.g. R01) in specific racial subgroups to personalize existing and novel therapeutics
around the NP system.
项目摘要/摘要
申请人Pankaj Arora医学博士是心血管科医学助理教授
阿拉巴马大学伯明翰分校的疾病。申请者的目标是成为一名独立的
临床和转化性研究的调查员,并促进对精神障碍是如何
利钠肽(NP)系统参与高血压、心力衰竭和心血管疾病的发展
疾病。申请人对遗传学、NP系统生物学和
能够进行高质量的以患者为中心的研究。指导了以患者为中心的研究生涯
发展奖(K23)描述了一个五年计划,该计划将允许申请者实现独立,如
一名调查员,在托马斯·J·王医学博士的主要指导下,他是国际公认的
NP生理学领域。申请人希望获得4个具体领域的知识和专业知识:(1)
以病人为中心的生理学研究,(2)心血管疾病种族差异的病理生理学基础
疾病易感性,(3)运动生理学,(4)以病人为中心的药理学研究。
非裔美国人心血管疾病患病率增加,这是造成种族差异的原因之一
死亡和住院等后果。NPS是一种利钠和扩张血管的激素,由
心脏对心房和心室壁应力增加的反应。在这项提案的前期工作中,
我们发现非裔美国人与NP缺乏症有关。对生理学知识知之甚少
在非裔美国人中发现较低的静息NP水平的后果。目前的提案将寻求
确定心脏对生理干扰的反应方式是否存在种族差异
运动和β-受体阻滞剂。具体目的是(1)比较非洲地区NP对β受体阻滞剂的反应。
美国人和白人个人(2)比较非裔美国人和白人对运动的NP反应
个人。了解这些NPs释放的差异可能具有生物学和治疗作用
在治疗高血压和心力衰竭方面的重要性。
以患者为导向的导师研究职业发展奖(K23)将为阿罗拉博士提供
充分参与多方面、精心设计的以患者为导向的研究方案所需的时间,同时
作为接受额外正式教学的一种手段。在授权期内,申请人
将在UAB公共学院攻读临床和转化学公共卫生理学硕士学位
提高他在以病人为中心的研究(流行病学、生物统计学、研究设计、赠款--
写作和领导力课程)。UAB丰富的协作、跨学科环境与国家
对社区参与的认可将为阿罗拉博士提供一个成功开展
计划中提出的研究。拟议的研究将使调查员准备好设计和实施
对特定种族亚群进行干预研究(例如R01),使现有和新的治疗方法个人化
围绕着NP系统。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Pankaj Arora其他文献
Pankaj Arora的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Pankaj Arora', 18)}}的其他基金
Natriuretic Peptide-Renin-Angiotensin-Aldosterone System Rhythm Axis and Nocturnal Blood Pressure
利钠肽-肾素-血管紧张素-醛固酮系统节律轴与夜间血压
- 批准号:
10545747 - 财政年份:2022
- 资助金额:
$ 19.38万 - 项目类别:
The Effects of Neprilysin Inhibition on Cardiometabolic Health in Black Individuals
脑啡肽酶抑制对黑人心脏代谢健康的影响
- 批准号:
10627738 - 财政年份:2022
- 资助金额:
$ 19.38万 - 项目类别:
Atrial Natriuretic Peptide and Regulation of Cardiometabolic Health: A Genotype-Guided Human Physiological Study
心钠素和心脏代谢健康的调节:基因型引导的人类生理学研究
- 批准号:
10627996 - 财政年份:2022
- 资助金额:
$ 19.38万 - 项目类别:
Natriuretic Peptide-Renin-Angiotensin-Aldosterone System Rhythm Axis and Nocturnal Blood Pressure
利钠肽-肾素-血管紧张素-醛固酮系统节律轴与夜间血压
- 批准号:
10342142 - 财政年份:2022
- 资助金额:
$ 19.38万 - 项目类别:
Atrial Natriuretic Peptide and Regulation of Cardiometabolic Health: A Genotype-Guided Human Physiological Study
心钠素和心脏代谢健康的调节:基因型引导的人类生理学研究
- 批准号:
10419574 - 财政年份:2022
- 资助金额:
$ 19.38万 - 项目类别:
The Effects of Neprilysin Inhibition on Cardiometabolic Health in Black Individuals
脑啡肽酶抑制对黑人心脏代谢健康的影响
- 批准号:
10276363 - 财政年份:2022
- 资助金额:
$ 19.38万 - 项目类别:
Race, Natriuretic Peptides and Physiological Perturbations
种族、利尿钠肽和生理干扰
- 批准号:
10397576 - 财政年份:2019
- 资助金额:
$ 19.38万 - 项目类别:
Race, Natriuretic Peptides and Physiological Perturbations
种族、利尿钠肽和生理干扰
- 批准号:
10591601 - 财政年份:2019
- 资助金额:
$ 19.38万 - 项目类别: